Juan García-Bernalt Diego

Postdoctoral researcher at Hospital 12 de Octubre

[Rafael Delgado @derafaeldelgado]

Excited to share our latest work on oral Ebola vaccines. Across two studies, we show that virus-like particles delivered orally induce robust humoral and cellular immunity and provide protection against lethal Ebola virus challenge in mice. @sev_virologia

[Hospital Universitario 12 de Octubre @H12Octubre]

💉 Avances en Ébola: el #H12O demuestra la viabilidad y eficacia de una vacuna oral contra una variante del virus

✅ Probada en ratones, es una base sólida para una futura inmunización contra otra variante, Bundibugyo, que afecta al Congo.

https://t.co/6bkU7dqgHN

#somosdel12

[Juan García-Bernalt Diego @BernaltJuan]

All thanks to the amazing team at @mschotsaert lab and collaborators

[Juan García-Bernalt Diego @BernaltJuan]

New preprint! Our combo TLR7/8 and RIG-I agonist adjuvant reverts allergic asthma in OVA-sensitized mice and protects from subsequent Influenza challenge. Exploring the role of immune skewing and genetic background in the process.
https://t.co/FfxQrfLTc7

[Science Immunology @SciImmunology]

A new Science #Immunology Review discusses how #vaccine #adjuvants function and highlight knowledge gaps that need to be addressed to develop improved vaccines against emerging pathogens. @kochinstitute @MITdeptofBE @scrippsresearch https://t.co/6wT9DAgf0B

[infoLibre @_infoLibre]

🥳 Nochevieja desde la redacción | 'Cosas cursis para cuando ya no sea Navidad', la opinión de @sli_rb https://t.co/AW1G6TiB4e

[Arthur Mortha @nkg2d1]

Ever wondered how gut microbes control immune responses at extra-intestinal locations?
Here, #theonlylabever reports how a gut protozoan commensal microbe remotely shapes pulmonary immunity to exacerbate asthma and limit the dissemination of mycobacteria.
@CellCellPress ⬇️(1/X)

[Michael Schotsaert @mschotsaert]

Our latest manuscript describing a preclinical model for #SARSCoV2 and #influenza #reinfection is out. #Macrophage responses rather than lymphocytes may drive the differences in disease outcome. @SinaiImmunol #SinaiMicro @GradSchoolSinai. https://t.co/g4QY0Hh6oT

[Juan García-Bernalt Diego @BernaltJuan]

Happy to share our work just published in @NatureComms! We investigate the differential role of prior SARS-CoV-2 and influenza exposure in the outcome of SARS-CoV-2 reinfections, depending on mouse genetic background. Amazing teamwork from @mschotsaert lab https://t.co/E945Q1KT2H

[Pedro Fernández-Soto @pedrofsoto]

Reciente el Capítulo 34 'Nucleic Acid Diagnostics' en el libro Handbook of Molecular Biotechnology https://t.co/Uj5SEhi7UN

This chapter hopes to draw readers' attention to the necessity to develop and increase availability of portable, fast and easy-to-use diagnostic tools.

[Pedro Fernández-Soto @pedrofsoto]

🙋‍♂️Another collaborative paper is out in Travel Medicine and Infectious Diseases.

Impact of species hybridization on the clinical management of schistosomiasis: a prospective study. https://t.co/pdXXSPmQ0E

Thanks to @UMTPoniente, @UV_EG and e-INTRo group of @IBSAL_IIS .

[Science Immunology @SciImmunology]

Controlled experimental infections with #Schistosoma mansoni reveal how the human #immune response to #schistosomiasis changes over time.

Read this research and more in the July issue of Science #Immunology: https://t.co/HR7ALenALh

[Sara Cuadrado Castaño PhD @squarechesnut]

Join us for the Biotech-Biopharma Summit next Thursday, the 27th, from 4 PM to 7 PM! Dive into how technology is already shaping the future of medicine! Few spots still available! Register #SalamancaTechSummit #PACBB2024 @usal #salamanca

[Pedro Fernández-Soto @pedrofsoto]

Premio extraordinario de doctorado de la @usal para tres de nuestros alumnos del grupo e-INTRO (Enfermedades Infecciosas y Tropicales)-@IBSAL_IIS y CIETUS. Magnífico trabajo.

[Juan García-Bernalt Diego @BernaltJuan]

@SesmaLab @mschotsaert @GradSchoolSinai @derafaeldelgado Thank you @SesmaLab for hosting me in your lab space all this time! Couldn't have asked for a better environment to be in!

[Juan García-Bernalt Diego @BernaltJuan]

@mschotsaert @GradSchoolSinai Such a privilege to have been a part of this amazing lab. And look out for @mschotsaert and the team, they have a lot of great science coming!

[Pedro Fernández-Soto @pedrofsoto]

No te pierdas el capítulo que hemos escrito sobre Schistosoma y schistosomiasis (Chapter 164: https://t.co/dw9ZCbUkop) en el libro Molecular Medical Microbiology (Third Edition) 2024; https://t.co/ySgiwlp7mc. Grupo e-INTRO, @IBSAL_IIS

[Michael Schotsaert @mschotsaert]

This makes my day. You’re looking at very very good T cell activation… Congrats Team! ⁦@IcahnMountSinai⁩ ⁦@GradSchoolSinai⁩

[Michael Schotsaert @mschotsaert]

We shared this before as preprint - now published in #PLOSPathogens: Breakthrough infections by #SARSCoV2 variants boost cross-reactive hybrid immune responses in mRNA vaccinated hamsters https://t.co/8LMqkaoZ0o.
@GradSchoolSinai
@IcahnInstitute
@SinaiImmunol #SinaiVirology

[Selina @sli_rb]

Hablé con el CEO de Moderna sobre el Nobel, las vacunas, restaurar coches y desconectar del trabajo. Por cierto, es más de llevar Ibuprofeno que de pedírselo a alguien en la oficina. https://t.co/aGOxRo8xFe via @el_pais